BACKGROUND: Classically, hypertrophic cardiomyopathy (HCM) has been viewed as a single-gene (monogenic) disease caused by ...

Dilated cardiomyopathy (DCM) is a heterogeneous disorder that is familial in approximately 30% of cases. Although several genes have been identified that can cause familial DCM, molecular analyses ...

“Hypertrophic cardiomyopathy can be an insidious disease, with some people having no obvious symptoms, while others may only feel symptoms with exercise or exertion,” said Andrew Wang, M.D., FAHA, ...

Acoramidis (Attruby; BridgeBio), a drug that stabilizes transthyretin and has demonstrated benefit on cardiovascular outcomes, has been approved by the US Food and Drug Administration for the ...

American Heart Association volunteer, co-chair of the Association's HCM Science Advisory Group and president of the Hypertrophic Cardiomyopathy Medical Society , a collaborator on the initiative.

Classification can be performed on structured or unstructured data. Classification is a technique where we categorize data into a given number of classes. The main goal of a classification problem is ...

Oussama Wazni, MD, Cleveland Clinic, discusses insights from the OPTION trial and their potential implication on guidelines for post-ablation management in atrial fibrillation.

Progress in assessing cardiovascular risk and identifying early prevention opportunities, improvements in treating heart ...

The office of Senate Majority Leader Chuck Schumer (D-N.Y.) said that this week he will bring the HEARTS Act, the bipartisan ...

PDUFA Target Action Date Set for September 26, 2025SOUTH SAN FRANCISCO, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated ...